Protocol I8B-MC-ITRN A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro, Both in Combination with Insulin Glargine or Insulin Degludec in Adults with Type 2 Diabetes

Trial Profile

Protocol I8B-MC-ITRN A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro, Both in Combination with Insulin Glargine or Insulin Degludec in Adults with Type 2 Diabetes

Recruiting
Phase of Trial: Phase III

Latest Information Update: 29 Jun 2018

At a glance

  • Drugs Insulin lispro (Primary) ; Insulin degludec; Insulin glargine
  • Indications Type 2 diabetes mellitus
  • Focus Registrational; Therapeutic Use
  • Acronyms PRONTO-T2D
  • Sponsors Eli Lilly
  • Most Recent Events

    • 09 Apr 2018 Planned End Date changed from 1 Jan 2019 to 1 Apr 2019.
    • 19 Feb 2018 Planned End Date changed from 15 Feb 2019 to 1 Jan 2019.
    • 19 Feb 2018 Planned primary completion date changed from 31 Aug 2018 to 1 Aug 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top